Am J Transplant, Volume 20, Suppl 3 Archives - Page 164 of 223 - ATC Abstracts

2020 American Transplant Congress
Incidence, Clinical Correlates and Outcomes of Pulmonary Hypertension after Kidney Transplantation: Analysis of Linked U.S. Registry and Medicare Billing Claims
K. Lentine¹, S. Costa², Y. Caliskan³, D. Levine⁴, J. Runo⁵, H. Te⁶, J. Rangaswami⁷, D. Dadhania⁸, D. Axelrod⁹, M. Schnitzler³, H. Xiao¹, B. Kasiske¹⁰, J. Snyder¹⁰, T. Villines¹¹
¹Department of Medicine, Saint Louis Univ, Saint Louis, MO, ²Dartmouth, Lebanon, NH, ³Saint Louis Univ, Saint Louis, MO, ⁴UT Health, San Antonio, TX, ⁵Univ of Wisconsin, Madison, WI, ⁶Univ of Chicago, Chicago, IL, ⁷Einstein Medical Ctr, Philadelphia, PA, ⁸Weill Cornell, New York, NY, ⁹Univ of Iowa, Iowa City, IA, ¹⁰SRTR, Minneapolis, MN, ¹¹Univ of Virginia, Charlottesville, VA
*Purpose: To describe the incidence and mortality implications of pulmonary hypertension (P-HTN) in a large, national cohort of US kidney transplant (KTx) recipients.*Methods: We examined…
2020 American Transplant Congress
The Evolution and Impact of ABMR Histology and Transplant Glomerulopathy in the Presence or Absence of HLA-DSA
M. Coemans¹, A. Senev¹, G. Verbeke², M. Emonds¹, M. Naesens¹
¹Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium, ²Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Leuven, Belgium
*Purpose: After kidney transplantation, the occurrence of ABMRh (=histological picture of antibody-mediated rejection) and transplant glomerulopathy (cg) has been reported, both in the presence and…
2020 American Transplant Congress
Multi-National Survey among Nephrologists and Transplant Surgeons About the Suitability and Acceptance of the Marginal Live Kidney Donors Regarding Age Discrepancy
Z. Arabi¹, S. Kaysi², A. Hamad³, M. Bukhari⁴, A. Mateen¹, E. Elhassan¹, A. Altheaby¹
¹KAMC, Riyadh, Saudi Arabia, ²CHR Orleans, Orleans, France, ³The Regional Medical Center, Orangeburg, SC, ⁴Taif University, Taif, Saudi Arabia
*Purpose: Living donor kidney transplantation is the best option for patients on dialysis. There are no guidelines or generally accepted consensus about the acceptable kidney…
2020 American Transplant Congress
Frailty Predicts Increased Length of Stay after Kidney Transplantation: An Implementation Study
J. Schaenman, B. Hale-Durbin, C. Lee, N. Ventigan, S. Jaladanki, L. Shih, B. Abdalla, R. Ahn, S. Chang, M. Dunbar-Forrest, H. A. Gritsch, G. Danovitch, D. Goldwater
David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: Our objective was to implement a standardized an assessment of physical frailty and other aging-associated syndromes during routine evaluation of kidney transplant candidates over…
2020 American Transplant Congress
11 Years Experience of Early Steroid Withdrawal Immunosupression Protocol in Kidney Allograft Recipient
O. Adebiyi, A. Sharfuddin, M. Yaqub, D. Mishler, T. Taber, W. Goggins
Indiana University, Indianapolis, IN
*Purpose: Early Steroid Withdrawal (ESW) Immunosuppression protocol has become a viable alternative to steroid based regimen. Our transplant program has adopted ESW protocol since 2003…
2020 American Transplant Congress
Molecular Diagnosis of Rejection in Liver Transplant Biopsies: The INTERLIVER Study
K. S. Madill-Thomsen¹, P. F. Halloran², .. The INTERLIVER Study Group³
¹Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Canada, ³., ., AB, Canada
*Purpose: Diagnosing rejection in liver transplant biopsies is challenging given the limitations of histology e.g. low kappa values among pathologists. A Molecular Microscope® Diagnostic system…
2020 American Transplant Congress
Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-institutional Study Of > 3000 Patients
P. Tabrizian¹, M. Holzner², V. Agopian³, R. Busuttil³, G. Sapisochin⁴, N. Mehta⁵, F. Yao⁵, J. Roberts⁶, S. Florman¹, M. E. Schwartz¹, T. Ivanics⁷, J. Emond⁸, B. Samstein⁹, R. Brown, MD, MPH⁹, M. Najjar¹⁰, W. Chapman¹¹, M. Doyle¹¹, K. Halazun⁹
¹Transplant, Mount Sinai Medical Center, New York, NY, ²Surgery, Georgetown University Hospital, Washington DC, MD, ³Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA, ⁴Transplant, Univeristy of Toronto, Toronto, ON, Canada, ⁵Transplant, UCSF, San Francisco, CA, ⁶Transplantation, UCSF, San Francisco, CA, ⁷Transplant, University of Toronto, Toronto, ON, Canada, ⁸Transplant, Columbia University Medical Center, New York, NY, ⁹Transplant, Weill Cornell Medical Center, New York, NY, ¹⁰Transplant, Columbia Medical Center, New York, NY, ¹¹Transplant, Washington University School of Medicine, St Louis, MO
*Purpose: Early recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) carries a poor prognosis. We aimed to develop a risk score for early HCC…
2020 American Transplant Congress
Live Donor Liver Transplant Offers Higher Survival, Improved Quality of Liver and Lower Morbidity for Recipients with Low MELD Score
M. Black, J. Bayer, H. Fernandez, E. Martinez, G. McKenna, N. Onaca, R. Ruiz, G. Testa, A. Wall, T. Ma, G. Saracino, S. Asrani, A. Gupta
Baylor University Medical Center, Dallas, TX
*Purpose: The shortage of cadaveric liver grafts contributes to significant waitlist mortality. Patients with low MELD-Na score (
2020 American Transplant Congress
Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant
J. Banbury¹, T. Loosier¹, C. Lin², K. Gutierrez¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL
*Purpose: In response to the ongoing organ shortage, ABO-incompatible (ABOi) renal transplant (RT) provides an alternative option for patients with end-stage kidney disease. Literature suggests…
2020 American Transplant Congress
Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients
S. J. Yusuf¹, H. Bheemreddy¹, A. Imtiaz², N. Krishnan³
¹Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom, ²Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, ³Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom
*Purpose: Over the years there has been a shift in the use of anti-metabolites agents from azathioprine to mycophenolate mofetil (MMF) based immunosuppression., due to…